Press Releases

Results of TAIslim System Studies Published in Prestigious Scientific Journal:
Participants Lost 6 Times More Body Fat!

Phoenix, AZ — December 31, 2011 — The results of several human clinical studies on FreeLife International’s TAIslim Total Body System have been recently published in the peer-reviewed Journal of Functional Foods in Health and Disease, thereby adding to a growing body of clinical evidence supporting the efficacy of the Company’s quadruple patent-pending fitness and weight loss supplement program.

In this important paper, which describes a rigorous 90-day randomized, double-blind, placebo-controlled human clinical study, participants using the products of the TAIslim System lost 4 times more body weight and 6 times more body fat than those using placebo alone, even under the same conditions of caloric intake, diet and exercise. The paper also discusses the unique mode of actions of TAIslim System, including significant appetite suppression and stimulation of energy expenditure (calorie burning). The System was found to reduce not only body weight and body fat, but also body mass index (BMI), waist and hip circumference, and to cause significant improvements in blood pressure and fasting glucose levels. These are considered as multiple risk factors of metabolic syndrome, diabetes, cardiovascular diseases, cancer and many others.

Speaking of this newly published research, Dr. Julie Campbell, a highly respected expert in atherosclerosis and cardiovascular disease research, said, “I was very impressed by the results showing that the TAIslim System controls appetite and energy expenditure by improving caloric metabolism, and as a consequence decreases body weight, waist and hip circumference and other anthropometric parameters. The study was very well planned and analysed and the results convincing. Congratulations on a wonderful result. The combination of the TAIslim products certainly will be a great asset to those people wishing to lose weight.”

Dr. Judith S. Stern, Distinguished Professor of Nutrition & Internal Medicine at University of California, Davis added, “The article is excellent, the methods are well-described, and the many outcome measures are supportive of decreases in some of the metabolic parameters that place a person at risk for metabolic syndrome and type 2 diabetes. This carefully-designed 12 week study clearly showed that, compared to people taking a placebo, those taking the TAIslim System lost more weight and were not hungry.”

According to principal investigator and FreeLife’s Chief Scientific Officer, Dr. Haru Amagase, “We are very encouraged by the results of our multiple human clinical studies on the TAIslim System. We believe that our research demonstrates great promise for those seeking safe, effective, and sustainable weight control. We are honored to have had our results published in leading scientific journals.”

Rick Handel, Chief Product Officer of FreeLife, commented “The TAIslim Total Body System is a result of FreeLife’s continuing commitment to cutting edge science and human clinical research. With four patents pending and rigorous scientific studies, no other weight loss or fitness product can approach the scientific innovation or clinically demonstrated efficacy and safety of the TAIslim System. To help individuals achieve negative caloric balance on a daily basis, the TAIslim System is composed of 3 products: TAIslim® Liquid (metabolic enhancement); TAIslim® SHAKE (advanced meal replacement), TAIslim® SKINNY™ (appetite controlling snack), and TAIslim® BOOSTERs (functional mix-ins for the SHAKE). Along with regular exercise and a healthy diet, the TAIslim System helps individuals reach and maintain a healthy weight.”

About Julie H. Campbell, Ph.D.
Dr. Julie H. Campbell is an expert in atherosclerosis research, and she studies impacts of various diets and nutrition on this serious disease. She received a doctorate in Cell Biology from the University of Melbourne. Prior to that, Dr. Campbell received a bachelor degree in Physiology from the University of New South Wales. She has published over 230 publications in international scientific journals, and she is the co-author of four books on cardiac muscle, vascular smooth muscle and tissue engineering of the arteries. She is also the author of Grow Your Own Designer Blood Vessels. Dr. Campbell is the recipient of a number of professional awards and honors, including The Queensland Businesswoman of the Year 2007 (Public and Not for Profit category), an Officer for the Order of Australia in the General Division, as well as the Queensland Greats Award. Dr. Campbell is a Fellow of the Australian Academy of Science and a member of a Sectional Committee. Additionally, she holds a patent for “Implant Material” in Australia and the United States, a pending patent in Europe, and a pending patent for “Bioreactors” in Australia.

Dr. Campbell is currently a full Professor and Director of the Center for Research at the University of Queensland, and an Emeritus Senior Principal Research Fellow of the National Health and Medical Research Council. She also serves as the Director of the Wesley Research Institute at the Wesley Hospital as a Senior Principle Research Fellow at the National Health and Medical Research Council (NHMRC), as well as President of the Association of Australian Medical Research Institutes.

About Judith S. Stern, Sc.D.
An expert on diet and nutrition, Dr. Judith S. Stern received her bachelor's degree in Foods and Nutrition from Cornell University and her doctor of science degree in Nutrition from Harvard University School of Public Health in Boston. She has been the recipient of numerous professional awards and honors, and has published more than 275 research papers in professional journals on topics such as obesity, exercise, and dietary supplements. Dr. Stern has also written over 150 articles in popular magazines such as Vogue and has contributed as an Editorial Advisor to Prevention magazine.

Dr. Stern co-founded the American Obesity Society, a lay advocacy organization dedicated to advancing the understanding of the disease of obesity. She currently serves as Distinguished Professor in both the College of Agriculture & Environmental Sciences and the School of Medicine at the University of California at Davis (UCD).

About Haru Amagase, Ph.D.
With a rich history in the nutraceutical industry, Dr. Haru Amagase has more than 28 years of experience in Research and Development, has published more than 35 scientific papers, and holds 13 patents.

About Rick Handel
Rick Handel is a 35-year veteran of the nutrition industry, with a strong background in formulation, research and development of dietary supplements. He holds numerous patents and has lectured extensively around the world.

About FreeLife International
Founded in 1995, FreeLife International is a financially solid, Inc. 500 Direct Sales company based in Phoenix, Arizona. Operating in 26 countries, FreeLife’s leading products are the clinically studiedTAIslim® System (TAIslim liquid, SKINNYs and SHAKE), GoChi®, Himalayan Goji® Juice, and Jule of the Orient™. FreeLife’s mission is “to serve each other by promoting good health, well-being and the opportunity for an abundant life.” This statement is used to guide company decisions every day – starting with the Co-Founders and emanating to all employees at the corporate offices and the sales representatives in the field. For more information, visit FreeLife.com.

FreeLife International Presented Results of Successful TAIslim® BOOSTERs Study at Annual Obesity Society Meeting

Orlando, FL — October 3, 2011 — FreeLife International presented the results of several human clinical studies on TAIslim BOOSTERs – the latest products in the Company’s proprietary quadruple-patent pending TAIslim Total Body System for weight management – at the annual Obesity Society Meeting. The meeting was held in Orlando from October 1 through 5, 2011, and was one of the world’s largest gatherings of obesity professionals including leading obesity scientists presenting cutting-edge research. The annual meeting provides essential educational and networking opportunities and is a forum for increasing knowledge, stimulating research, and promoting better treatment for those affected by the disease of obesity.

FreeLife’s Chief Scientific Officer Dr. Haru Amagase, along with co-investigator and Chief Product Officer Rick Handel, presented research on the impact of the TAIslim System on weight management. They discussed the unique benefits of TAIslim Super Fruits and Super Greens BOOSTERs, including: a significant increase of preference of the TAIslim SHAKE meal replacement when mixed with BOOSTERs; and stimulation of energy expenditure (calorie burning) that was observed in several randomized, double-blind, placebo-controlled human clinical studies. As the System was found to significantly reduce body weight, body mass index (BMI), and waist and hip circumferences, total body fat content in previous studies, adding BOOSTERs to the existing System will be a great addition to increase its potency and efficacy.

According to co-investigator and Chief Product Officer Rick Handel, “Many people simply do not consume enough healthy fruits and vegetables, although they are some of the best foods for achieving and maintaining a healthy weight. TAIslim BOOSTERS are ideal, as they add the phytonutrient power of 28 fruits or 32 vegetables, herbs, and other healthful green foods. Each scoop delivers the antioxidant strength of five servings of vegetables or fruits, while helping the body to burn even more calories.”

Dr. Amagase added, “These clinical study results are very important for those who continue to pursue weight management. Over time, daily use of even the best-tasting meal replacement shakes can become somewhat boring. BOOSTERs add variety of taste, and will help people to stay compliant with the TAIslim System so they can maintain a healthy dietary caloric intake. We believe that our research demonstrates great promise for those seeking safe, effective, and sustainable weight control.”

The TAIslim Total Body System is a result of FreeLife’s continuing commitment to cutting edge science and human clinical research. With four patents pending and rigorous scientific studies, no other weight management product can approach the scientific innovation or clinically demonstrated efficacy of the TAIslim System.

About Haru Amagase, Ph.D.
With a rich history in the nutraceutical industry, Dr. Haru Amagase has more than 28 years of experience in Research and Development, has published more than 35 scientific papers, and holds 13 patents.

About Rick Handel
Rick Handel is a 35-year veteran of the nutrition industry, with a strong background in formulation, research and development of dietary supplements. He holds numerous patents and has lectured extensively around the world.

About FreeLife International
Founded in 1995, FreeLife International is a financially solid, Inc. 500 Direct Sales company based in Phoenix, Arizona. Operating in multiple countries, FreeLife’s leading products are the clinically studied TAIslim® System (TAIslim SHAKE, liquid, SKINNYs, and BOOSTERs), GoChi®, Himalayan Goji® Juice, and Jule of the Orient®. FreeLife’s mission is “to serve each other by promoting good health, well-being and the opportunity for an abundant life.” This statement is used to guide company decisions every day – starting with the Co-Founders and emanating to all employees at the corporate offices and the sales representatives in the field. For more information, visit FreeLife.com.

FreeLife International^® Presents Results of Successful TAIslim Total Body System Studies at Obesity 2010 Meeting

San Diego, CA — October 9, 2010 — FreeLife International^® presented the results of several human clinical studies on TAIslim Total Body System, a proprietary triple-patent pending weight management supplement system, at the Obesity Society Annual Meeting. The Obesity Society annual meeting is the event of the year for obesity professionals in all stages of their careers. The meeting, which was held in San Diego from October 8 through 13, 2010, brought together the leading players in the field of obesity; from world-renowned speakers, researchers and clinicians to educators, advocators, policymakers and practitioners. The meeting provided essential educational and networking opportunities and is a forum for increasing knowledge, stimulating research, and promoting better treatment for those affected. http://www.obesity.org/

FreeLife's Chief Scientific Officer Dr. Haru Amagase presented findings, resulting from research collaboration with Chief Product Officer Rick Handel, on the impact that the TAIslim System has on weight management. They discussed the TAIslim System's unique mode of action: significant reductions in appetite and stimulation of energy expenditure (calorie burn), observed in several randomized, double-blind, placebo-controlled human clinical studies. The system was found to reduce body weight, body mass index (BMI), and waist and hip circumferences, and to cause significant improvements in blood pressure, fasting glucose levels and total body fat content. In one 90-day controlled trial, subjects using the products of the TAIslim System lost 4 times more body weight and 6 times more body fat than those using placebo, diet and exercise alone.

"These results are very interesting and promising" remarked Dr. Marie-Pierre St-Onge, noted obesity research expert and Research Associated at the New York Obesity Research Center at St. Luke's/Roosevelt Hospital and Assistant Professor at Columbia University. She added, "The rise in energy expenditure and reduction in self-reported appetite level with these products is interesting and suggests a mechanism by which they can assist in weight management."

According to clinical study Investigator, Dr. Haru Amagase, "We are very encouraged by the results of our multiple human clinical studies on the TAIslim System. We believe that our research demonstrates great promise for those seeking safe, effective, and sustainable weight control. We are honored to have the opportunity to share our study results with the best and brightest experts and scientists in obesity research."

The TAIslim Total Body System is a result of FreeLife's continuing commitment to cutting edge science and human clinical research. With three patents pending and rigorous scientific studies, no other weight loss product can approach the scientific innovation or clinically demonstrated efficacy of the TAIslim System.

About Marie-Pierre St-Onge, Ph.D.
Dr. St-Onge is Research Associate at the New York Obesity Research Center at St. Luke's/Roosevelt Hospita, and Assistant Professor at Columbia University. Dr. St-Onge is an expert in obesity research, with primary research interests including the study of functional foods for body weight control and cardiovascular disease prevention. She examines the effects of various whole foods or food components on energy balance, thermogenesis and appetite/food intake, as well as on metabolic risk factors, such as lipids, insulin, and glucose. She uses indirect calorimetry to assess energy expenditure and magnetic resonance imaging, dual energy X-ray absorptiometry, and computed tomography to examine the ultimate effects of various dietary interventions on body composition. Dr. St-Onge is also interested in the effects of foods on brain responses to food stimuli, using functional magnetic resonance imaging. Dr. St-Onge has won numerous awards and in addition to her published research, she has also co-authored several book chapters. Dr. St-Onge brings her expertise to FreeLife by serving on the Company's independent Scientific Advisory Board.

About Haru Amagase, Ph.D.
With a rich history in the nutraceutical industry, Dr. Haru Amagase has more than 28 years of experience in Research and Development, has published more than 35 scientific papers, and holds 13 patents.

About Rick Handel
Rick Handel is a 35-year veteran of the nutrition industry, with a strong background in formulation, research and development of dietary supplements. He holds numerous patents and has lectured extensively around the world.

About FreeLife International
Founded in 1995, FreeLife International is a financially solid company based in Phoenix, Arizona. Operating in 26 countries, FreeLife's leading products are the clinically studied TAIslim System (TAIslim^® liquid, SKINNYs™ and TAIslim^® SHAKE), GoChi^®, Himalayan Goji^® Juice, and Jule of the Orient^®. FreeLife's mission is "to serve each other by promoting good health, well-being and the opportunity for an abundant life." This statement is used to guide company decisions every day starting with the Co-Founders and emanating to all employees at the corporate offices and the sales representatives in the field. For more information, visit FreeLife.com.

FreeLife International^® Presents Clinical Research at Major Scientific Conference

ANAHEIM, CA – April 28, 2010 FreeLife International^® presented the results of six human clinical studies on its innovative nutritional products at the recent 2010 Experimental Biology meeting, which was attended by about 13,000 scientists representing total 24 disciplines, such as of nutrition, anatomy, biochemistry, pharmacology, and immunology.

FreeLife’s Chief Scientific Officer Dr. Haru Amagase presented results of human trials of the company’s Jule of the Orient®, a tonic based on the traditional Chinese herb jiaogulan, showing benefits on resting metabolic rate, blood circulation, and general well-being.

Dr. Dwight Nance, a noted neuroimmunologist and professor at the University of California, says the studies show Jule’s potential. “The rise in energy expenditure and increased circulation observed with this jiaogulan-based product suggests a mechanism by which it can improve feelings of general well-being,” Dr. Nance said.

Dr. Amagase also described FreeLife’s weight management product TAIslim®   and the significant weight loss and general health improvements observed in several human clinical studies. Also discussed at the conference were study results on GoChi®, FreeLife’s industry-leading goji juice product.

Dr. Marie-Pierre St Onge, noted obesity research expert who is a professor at the New York Obesity Research Center at Columbia University, called the TAIslim and GoChi study results “very promising.” She added, “The rise in energy expenditure with these goji-based products suggests a mechanism by which they can assist in weight management.”

FreeLife’s research findings will be published in an upcoming edition of the respected Journal of the Federation of American Societies for Experimental Biology.

Phoenix-based FreeLife prides itself on its science-based approach to the formulation of nutritional supplements. “Our ongoing commitment to rigorous human clinical research is what distinguishes FreeLife from other nutrition companies,” Dr. Amagase said. “Our work has demonstrated great promise for those seeking better health.”

FreeLife International is a leading nutritional company founded in 1995. Listed among the Inc. 500 Direct Sales companies, FreeLife operates in 26 countries.

FreeLife International^® Presents Results of Successful Clinical Studies at Annual Obesity Society Meeting

PHOENIX, AZ October 28, 2009 FreeLife International^® recently presented the significant results of several human clinical studies on TAIslim^®, its proprietary triple patent pending liquid weight management supplement, at the 27th Annual Scientific Meeting of The Obesity Society. This important conference, held in Washington, DC, brought together the world's leading players in the field of obesity from basic and clinical researchers and clinicians to educators, advocates, policy shapers, and practitioners.

At the conference, FreeLife’s Chief Scientific Officer Dr. Haru Amagase presented research on the impact of TAIslim on weight management. He discussed TAIslim's unique mode of action and the significant reductions in body weight, body mass index (BMI), waist and hip circumferences observed in several controlled human clinical studies. TAIslim was also found to cause significant improvements over placebo in blood pressure, fasting glucose levels, and total body fat content. The formula was developed after weight management benefits were noted in clinical studies on two other FreeLife supplements – GoChi® and Chi3 Energy™, both of which are based on the Asian goji berry (Lycium barbarum).

FreeLife’s findings on TAIslim will be published in the respected journal Obesity. “These results are very interesting and promising,” remarked Dr. Marie-Pierre St-Onge, noted obesity research expert and Assistant Professor at St. Luke's/Roosevelt Hospital and New York Obesity Research Center at Columbia University.   She added, “The rise in energy expenditure (i.e., fat burning) with these goji-based products is interesting and suggests a mechanism by which they can assist in weight management.”

"Lycium barbarum is a very interesting herb,” stated Dr. Norman R. Farnsworth, world-renowned Professor of Pharmacognosy (study of plant-based medicines) at the University of Illinois at Chicago. “Clinical studies have shown multiple health benefits for humans, especially for general well-being, for immune-modulation, and for its antioxidant effects. The medicinal properties of Lycium barbarum in traditional Asian medicine correlate well with recent scientific studies. It appears that the active compounds in Lycium barbarum are polysaccharides (LBP) on which the TAIslim product is standardized.”

FreeLife® is the first company to perfect a difficult and demanding proprietary process and create the most highly standardized form of the goji berry available in the world today. According to FreeLife’s Dr. Amagase, “TAIslim is the only product on the market that combines standardized goji LBP with a proprietary blend of synergistic natural ingredients, and we believe that our research demonstrates great promise for those seeking safe, effective and sustainable weight control. We are honored to have the opportunity to share our significant study results with the best and brightest experts and scientists in obesity research.”

With three patents pending, the TAIslim formula is a result of FreeLife’s continuing commitment to cutting-edge science and human clinical research. No other weight loss product can approach TAIslim’s exclusive formula, scientific innovation, or clinically demonstrated efficacy.

FreeLife is the first company to perfect a difficult and demanding proprietary process and create the only standardized form of this incredible plant available in the world today.

About Marrie-Pierre St-Onge, Ph.D.
Dr. St-Onge is Assistant Professor at St. Luke's/Roosevelt Hospital, and New York Obesity Research Center, Columbia University. Dr. St-Onge is the expert of obesity research and her main research interests include the study of functional foods for body weight control and cardiovascular disease prevention. She examines the effects of various whole foods or food components on energy balance, thermogenesis and appetite/food intake, as well as on metabolic risk factors, such as lipids, insulin, and glucose. She uses indirect calorimetry to assess energy expenditure and magnetic resonance imaging, dual energy X-ray absorptiometry, and computed tomography to examine the ultimate effects of various dietary interventions on body composition. Dr. St-Onge is also interested in the effects of foods on brain responses to food stimuli, using functional magnetic resonance imaging. Dr. St-Onge has won numerous awards and has publications with co-authored several book chapters.

About Norman R. Farnsworth, Ph.D.
Dr. Norman Farnsworth has been a pioneer in the development of collaborative research efforts in Pharmacognosy throughout his career. His original research publications number over 500 and have established him as a botanicals expert in both the national and international communities. He has been a member of the World Health Organization Expert Advisory Panel on Traditional Medicine since 1979, and also serves as the Director of the UIC/NIH (National Institutes of Health) Center for Botanical Dietary Supplements Research. Dr. Farnsworth serves as a Research Professor of Pharmacognosy, Distinguished University Professor and Director of the Program for Collaborative Research in the Pharmaceutical Sciences at the College of Pharmacy at the University of Illinois at Chicago (UIC) and helps FreeLife as one of the independent Scientific Advisory Board members.

About Haru Amagase, Ph.D.
With a rich history in the nutraceutical industry, Dr. Haru Amagase has more than 27 years of experience in Research and Development, has published more than 35 scientific papers, and holds 13 patents.

About Rick Handel
Rick Handel is a 35-year veteran of the nutrition industry, with a strong background in formulation, research and development of dietary supplements. He holds numerous patents and has lectured extensively around the world.

About FreeLife International
Founded in 1995, FreeLife International is a financially solid company based in Phoenix, Arizona. Operating in 26 countries, FreeLife's leading products are the clinically studied TAIslim System (TAIslim^® liquid, SKINNYs™ and TAIslim^® SHAKE), GoChi^®, Himalayan Goji^® Juice, and Jule of the Orient^®. FreeLife's mission is "to serve each other by promoting good health, well-being and the opportunity for an abundant life." This statement is used to guide company decisions every day starting with the Co-Founders and emanating to all employees at the corporate offices and the sales representatives in the field. For more information, visit FreeLife.com.